Literature DB >> 34173617

Diagnostic tool or screening programme? Asymptomatic testing for SARS-CoV-2 needs clear goals and protocols.

Jordan P Skittrall1,2,3, Mary D Fortune4, Hamid Jalal3, Hongyi Zhang3,5, David A Enoch3, Nicholas M Brown3, Anne Swift4.   

Abstract

Entities:  

Year:  2020        PMID： 34173617      PMCID： PMC7834146          DOI： 10.1016/j.lanepe.2020.100002

Source DB:  PubMed          Journal:  Lancet Reg Health Eur


× No keyword cloud information.
  37 in total

1.  Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'.

Authors:  Enrico Lavezzo; Elisa Franchin; Constanze Ciavarella; Gina Cuomo-Dannenburg; Luisa Barzon; Claudia Del Vecchio; Lucia Rossi; Riccardo Manganelli; Arianna Loregian; Nicolò Navarin; Davide Abate; Manuela Sciro; Stefano Merigliano; Ettore De Canale; Maria Cristina Vanuzzo; Valeria Besutti; Francesca Saluzzo; Francesco Onelia; Monia Pacenti; Saverio G Parisi; Giovanni Carretta; Daniele Donato; Luciano Flor; Silvia Cocchio; Giulia Masi; Alessandro Sperduti; Lorenzo Cattarino; Renato Salvador; Michele Nicoletti; Federico Caldart; Gioele Castelli; Eleonora Nieddu; Beatrice Labella; Ludovico Fava; Matteo Drigo; Katy A M Gaythorpe; Alessandra R Brazzale; Stefano Toppo; Marta Trevisan; Vincenzo Baldo; Christl A Donnelly; Neil M Ferguson; Ilaria Dorigatti; Andrea Crisanti
Journal:  Nature       Date:  2020-06-30       Impact factor: 49.962

2.  Covid-19: Government plans to spend £100bn on expanding testing to 10 million a day.

Authors:  Gareth Iacobucci; Rebecca Coombes
Journal:  BMJ       Date:  2020-09-09

3.  Screening for COVID-19 in Asymptomatic Patients With Cancer in a Hospital in the United Arab Emirates.

Authors:  Humaid O Al-Shamsi; Eric A Coomes; Sadir Alrawi
Journal:  JAMA Oncol       Date:  2020-10-01       Impact factor: 31.777

4.  Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting.

Authors:  Jordan P Skittrall; Michael Wilson; Anna A Smielewska; Surendra Parmar; Mary D Fortune; Dominic Sparkes; Martin D Curran; Hongyi Zhang; Hamid Jalal
Journal:  Clin Microbiol Infect       Date:  2020-10-14       Impact factor: 8.067

5.  The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship.

Authors:  Jon C Emery; Timothy W Russell; Yang Liu; Joel Hellewell; Carl Ab Pearson; Gwenan M Knight; Rosalind M Eggo; Adam J Kucharski; Sebastian Funk; Stefan Flasche; Rein Mgj Houben
Journal:  Elife       Date:  2020-08-24       Impact factor: 8.140

6.  Social patterning of screening uptake and the impact of facilitating informed choices: psychological and ethical analyses.

Authors:  Rachel Crockett; Timothy M Wilkinson; Theresa M Marteau
Journal:  Health Care Anal       Date:  2007-06-28

7.  Point of Care Nucleic Acid Testing for SARS-CoV-2 in Hospitalized Patients: A Clinical Validation Trial and Implementation Study.

Authors:  Dami A Collier; Sonny M Assennato; Ben Warne; Nyarie Sithole; Katherine Sharrocks; Allyson Ritchie; Pooja Ravji; Matthew Routledge; Dominic Sparkes; Jordan Skittrall; Anna Smielewska; Isobel Ramsey; Neha Goel; Martin Curran; David Enoch; Rhys Tassell; Michelle Lineham; Devan Vaghela; Clare Leong; Hoi Ping Mok; John Bradley; Kenneth G C Smith; Vivienne Mendoza; Nikos Demiris; Martin Besser; Gordon Dougan; Paul J Lehner; Mark J Siedner; Hongyi Zhang; Claire S Waddington; Helen Lee; Ravindra K Gupta
Journal:  Cell Rep Med       Date:  2020-07-15

8.  Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.

Authors:  Juanjuan Zhao; Quan Yuan; Haiyan Wang; Wei Liu; Xuejiao Liao; Yingying Su; Xin Wang; Jing Yuan; Tingdong Li; Jinxiu Li; Shen Qian; Congming Hong; Fuxiang Wang; Yingxia Liu; Zhaoqin Wang; Qing He; Zhiyong Li; Bin He; Tianying Zhang; Yang Fu; Shengxiang Ge; Lei Liu; Jun Zhang; Ningshao Xia; Zheng Zhang
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079

9.  Dexamethasone in Hospitalized Patients with Covid-19.

Authors:  Peter Horby; Wei Shen Lim; Jonathan R Emberson; Marion Mafham; Jennifer L Bell; Louise Linsell; Natalie Staplin; Christopher Brightling; Andrew Ustianowski; Einas Elmahi; Benjamin Prudon; Christopher Green; Timothy Felton; David Chadwick; Kanchan Rege; Christopher Fegan; Lucy C Chappell; Saul N Faust; Thomas Jaki; Katie Jeffery; Alan Montgomery; Kathryn Rowan; Edmund Juszczak; J Kenneth Baillie; Richard Haynes; Martin J Landray
Journal:  N Engl J Med       Date:  2020-07-17       Impact factor: 91.245

10.  High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19: Prospective cohort study, England.

Authors:  Shamez N Ladhani; Anna Jeffery-Smith; Monika Patel; Roshni Janarthanan; Jonathan Fok; Emma Crawley-Boevey; Amoolya Vusirikala; Elena Fernandez Ruiz De Olano; Marina Sanchez Perez; Suzanne Tang; Kate Dun-Campbell; Edward Wynne- Evans; Anita Bell; Bharat Patel; Zahin Amin-Chowdhury; Felicity Aiano; Karthik Paranthaman; Thomas Ma; Maria Saavedra-Campos; Joanna Ellis; Meera Chand; Kevin Brown; Mary E Ramsay; Susan Hopkins; Nandini Shetty; J Yimmy Chow; Robin Gopal; Maria Zambon
Journal:  EClinicalMedicine       Date:  2020-11-06
View more
  7 in total

Review 1.  Testing at scale during the COVID-19 pandemic.

Authors:  Tim R Mercer; Marc Salit
Journal:  Nat Rev Genet       Date:  2021-05-04       Impact factor: 59.581

2.  Risk stratification by anamnesis increases SARS-CoV-2 test efficiency in cancer patients.

Authors:  Christian Cornelius Arnold; Jens von der Grün; Mark Christoph Brekner; Jörg Licher; Emmanouil Fokas; Claus Rödel; Maximilian Fleischmann
Journal:  Strahlenther Onkol       Date:  2021-10-07       Impact factor: 3.621

3.  Quantifying pupil-to-pupil SARS-CoV-2 transmission and the impact of lateral flow testing in English secondary schools.

Authors:  Trystan Leng; Edward M Hill; Alex Holmes; Emma Southall; Robin N Thompson; Michael J Tildesley; Matt J Keeling; Louise Dyson
Journal:  Nat Commun       Date:  2022-03-01       Impact factor: 14.919

4.  Guiding organisational decision-making about COVID-19 asymptomatic testing in workplaces: mixed-method study to inform an ethical framework.

Authors:  Jan W van der Scheer; Akbar Ansari; Meredith McLaughlin; Caitríona Cox; Kathleen Liddell; Jenni Burt; Jenny George; Rebecca Kenny; Ruth Cousens; Brandi Leach; James McGowan; Katherine Morley; Janet Willars; Mary Dixon-Woods
Journal:  BMC Public Health       Date:  2022-09-15       Impact factor: 4.135

5.  A rapid RT-LAMP SARS-CoV-2 screening assay for collapsing asymptomatic COVID-19 transmission.

Authors:  Rebecca C Allsopp; Caroline M Cowley; Ruth C Barber; Carolyn Jones; Christopher W Holmes; Paul W Bird; Shailesh G Gohil; Claire Blackmore; Martin D Tobin; Nigel Brunskill; Philip N Baker; Jacqui A Shaw
Journal:  PLoS One       Date:  2022-09-01       Impact factor: 3.752

6.  Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making.

Authors:  James D Nichols; Tiffany L Bogich; Emily Howerton; Ottar N Bjørnstad; Rebecca K Borchering; Matthew Ferrari; Murali Haran; Christopher Jewell; Kim M Pepin; William J M Probert; Juliet R C Pulliam; Michael C Runge; Michael Tildesley; Cécile Viboud; Katriona Shea
Journal:  PLoS Biol       Date:  2021-06-17       Impact factor: 8.029

7.  SARS-CoV-2 screening: effectiveness and risk of increasing transmission.

Authors:  Jordan P Skittrall
Journal:  J R Soc Interface       Date:  2021-07-21       Impact factor: 4.118
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.